Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study

Table 2 Relationship between CTD-2547G23.4 expression and clinical parameters in qRT-PCR

Clinicopathological feature	n	CTD-2547G23.4 relevant expression in qRT-PCR
Clinicopathological feature	n	M ± SD	t	P
Tissue
Adjacent non-tumour tissues	39	1.8133 ± 0.7835	3.556^a	0.001
HCC	39	2.4646 ± 0.8332	3.556^a	0.001
Gender
Male	29	2.4124 ± 0.8563	− 0.661	0.512
Female	10	2.6160 ± 0.7845	− 0.661	0.512
Age (years)
< 50	18	2.2156 ± 0.8285	1.777	0.084
≥ 50	21	2.6781 ± 0.7949	1.777	0.084
Pathologic tumour
TI–II	25	2.4428 ± 0.7728	− 0.216	0.830
TIII–IV	14	2.5036 ± 0.9612	− 0.216	0.830
Nodes
Single	34	2.4444 ± 0.8282	− 0.390	0.698
Multi	5	2.6020 ± 0.9537	− 0.390	0.698
Metastasis
No	36	2.3906 ± 0.6916	− 0.882	0.469
Yes	3	3.3533 ± 1.88057	− 0.882	0.469
Embolus
No	38	2.4821 ± 0.8371	0.804	0.426
Yes	1	1.8000	0.804	0.426
Status
Alive	17	2.4688 ± 0.9286	0.225	0.824
Death	7	2.5586 ± 0.7667	0.225	0.824
Diameter (cm)
< 5	11	2.3573 ± 0.7985	− 0.499	0.621
≥ 5	28	2.5068 ± 0.8569	− 0.499	0.621
Vascular infiltration
No	33	2.4570 ± 0.7447	− 0.133	0.895
Yes	6	2.5067 ± 1.3130	− 0.133	0.895
Tumor capsular infiltration
Infiltration or no capsule	14	2.3057 ± 0.8561	0.889	0.380
With complete capsule	25	2.5536 ± 0.8241	0.889	0.380
Differentiation
Low	10	2.2240 ± 0.5027	F = 2.047^b	0.144
Moderate	25	2.4448 ± 0.8506
High	4	3.1900 ± 1.1612
AFP
No	21	2.5957 ± 1.0130	− 0.619	0.541
Yes	12	2.4192 ± 0.6248	− 0.619	0.541
Cirrhosis
No	25	2.6456 ± 0.8324	− 1.872	0.069
Yes	14	2.1414 ± 0.7580	− 1.872	0.069

ISSN: 1475-2867